Ahmed Shahr Eldin | Radiotherapy | Best Researcher Award

Posted on by Academic achievements

Assoc. Prof. Dr. Ahmed Shahr Eldin | Radiotherapy | Best Researcher Award

Assoc. Prof. Dr. Ahmed Shahr Eldin | Radiotherapy – Associate Professor at Atomic Energy Authority, Egypt

Ahmed Mohamed Shahr El-Din is an accomplished scientist in the field of chemistry, specializing in nuclear technology and radioactive waste management. He has significantly contributed to the development and purification of rare earth elements, as well as the safe handling and management of radioactive materials. With a career spanning over a decade, his research has not only focused on the technological advancements of chemical processes but has also emphasized the practical applications of these innovations in medical, industrial, and environmental contexts. Through his extensive experience and dedication, he has established himself as a key figure in the scientific community, both in Egypt and internationally.

Profile Verified

Google Scholar

Education

Ahmed Mohamed Shahr El-Din pursued his academic journey with an unwavering commitment to deepening his knowledge of chemistry and nuclear science. He earned his Bachelor’s degree in Chemistry from Zagazig University in 2003, followed by a Master’s degree in Chemistry from Benha University in 2014. His passion for nuclear chemistry led him to pursue a Ph.D. in Chemistry from Ain Shams University in 2017. His research during his doctoral studies focused on the separation and purification of rare earth elements, positioning him as an expert in the field. Alongside his academic qualifications, he has completed several specialized courses in radiochemistry and biochemical techniques, further enhancing his research proficiency.

Experience

Ahmed Mohamed Shahr El-Din’s professional career has been built on a foundation of practical experience in both research and application of nuclear chemistry. He currently serves as an Associate Professor at the Egyptian Atomic Energy Authority (EAEA), a position he has held since 2023. Prior to this, he served as a researcher at the same institution from 2017 to 2022, where he contributed to multiple research projects involving radioactive waste management and the development of purification technologies for medical radioisotopes. His postdoctoral work at the Institut des Sciences Moléculaires de Marseille in France further expanded his expertise in radiochemical processes, allowing him to collaborate on international projects aimed at advancing the purification and safe management of radionuclides. His involvement in several high-impact projects, including the development of nuclear technologies for medical applications, has garnered him recognition in the scientific community.

Research Interests

Ahmed Mohamed Shahr El-Din’s research interests lie at the intersection of chemistry, nuclear science, and environmental sustainability. His work focuses on the development of innovative techniques for the separation and purification of rare earth elements and naturally occurring radionuclides from mineral deposits. He has also contributed to the field of radioactive waste management, with a focus on the safe handling, disposal, and treatment of both solid and liquid radioactive waste. In addition to his work on nuclear waste, Shahr El-Din is dedicated to exploring the potential use of radioactive materials in medical applications, particularly the production of radioisotopes for diagnostic and therapeutic purposes. His work has not only advanced fundamental scientific knowledge but has also had significant real-world applications in the fields of healthcare, industry, and environmental safety.

Awards

Throughout his career, Ahmed Mohamed Shahr El-Din has received several prestigious awards and recognitions for his outstanding contributions to the field of nuclear chemistry. His research has been funded by major scientific organizations such as the Egyptian Academy of Scientific Research and the International Atomic Energy Agency (IAEA), reflecting the impact of his work on the global stage. He has been recognized for his contributions to the safe handling of radioactive materials and for his innovative solutions to challenges in the purification of rare earth elements and medical radioisotope production. His dedication to both scientific advancement and the practical application of his research has earned him a respected place in the international scientific community.

Publications

Shahr El-Din, A.M., Gizawy, M.A., Borai, E.H. (2024). “Radiochemical separation of 161Tb from neutron irradiated Gd target by liquid-liquid extraction technique.” Radiochimica Acta. https://doi.org/10.1515/ract-2024-0286 🌟
Gizawy, M.A., Shahr El-Din, A.M., Borai, E.H., Mohamed, N.M.A. (2024). “Production and radiochemical separation of Tb-161 as a feasible beta therapeutic radioisotope from reactor irradiated Gd target.” Journal of Chromatography A. 1737, 465439. 🌍
Shaltout, M., Kandil, S., El‑Tabl, A.S., Aglan, H., Shahr El-Din, A.M., Mohamed, Y.T. (2024). “A prototype system for the removal of 137Cs from liquid radioactive waste using reverse osmosis membrane.” Environ Sci Pollut Res Int, 31(23), 34112-34123. 💧
Shahr El-Din, A.M., El Afifi, E.M., Hilal, M.A. (2024). “Utilization of Organic Substrates for Remediation of TENORM Waste Generated from Some Strategic Industries.” Chemistry Africa, 7:3703–3715. 🌿
Shahr El-Din, A.M., Rizk, H.E., Borai, E.H., Afifi, E.M. (2023). “Selective separation and purification of cerium (III) from concentrate liquor associated with monazite processing by cationic exchange resin as adsorbent.” Chem. Pap. ⚛️
Shahr El-Din, A.M., Rizk, H.E., Attallah, M.F. (2023). “Purification of Carrier-Free 47Sc of Biomedical Interest: Selective Separation Study from natCa(n, γ).” Separations, 10, 8.🔬
Masry, B.A., Shahr El-Din, A.M., El-saied, H.A. (2022). “Ceric-ions redox initiating technique for Zirconium and Niobium separation through graft copolymerization of natural polysaccharides.” Sep. Sci. Technol., 57(4), 603-618. 💡

Conclusion

Ahmed Mohamed Shahr El-Din’s exemplary academic background, extensive research experience, and numerous contributions to the fields of nuclear chemistry, radioactive waste management, and rare earth element separation make him an outstanding candidate for the Best Researcher Award. His innovative research, focused on addressing critical environmental and medical challenges, has had a profound impact both nationally and internationally. Shahr El-Din’s work exemplifies the power of scientific research to solve pressing global issues, and his continued dedication to advancing nuclear science and environmental sustainability ensures that his future contributions will continue to shape the field for years to come.

Mohammad Amin Javidi | COVID-19 and cancer | Young Scientist Award

Posted on by Academic achievements

Dr. Mohammad Amin Javidi | COVID-19 and cancer | Young Scientist Award 

Faculty member at Department of Integrative Oncology, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran

Dr. Mohammad Amin Javidi is a dedicated researcher and an Assistant Professor in the Integrative Oncology Department at the Breast Cancer Research Center, Motamed Cancer Institute, Tehran, Iran. His work primarily focuses on the molecular underpinnings of cancer and developing innovative therapeutic strategies. With a strong foundation in molecular genetics, Dr. Javidi’s research has explored the interface of cancer treatment and viral infections, particularly the impact of COVID-19 on cancer outcomes. His commitment to advancing scientific knowledge is evidenced by numerous peer-reviewed publications and a track record of academic excellence, earning him recognition in both national and international scientific communities.

Profile

ORCID

Education

Dr. Javidi’s academic journey began with a Bachelor of Science in Genetics from Shahrekord University, Iran, where he graduated top of his class in 2010. He continued to excel in his studies, pursuing a Master of Science in Molecular Genetics at Tarbiat Modares University, Tehran, Iran, graduating first in his class in 2012. His passion for genetics led him to a Ph.D. program at the same institution, where he specialized in molecular genetics, completing his degree in 2017. His doctoral research was recognized for its excellence, earning him the first rank in his graduating class, demonstrating his strong academic dedication.

Experience

With years of experience in the field of molecular genetics and oncology, Dr. Javidi has built a career around the practical application of genetic research to cancer treatment. As an assistant professor at the Motamed Cancer Institute, he conducts research that bridges molecular biology and clinical oncology, focusing on the impact of molecular changes on cancer progression and therapeutic responses. His expertise spans a variety of laboratory techniques, including PCR, cell culture, flow cytometry, and in vivo experiments, which he uses to investigate novel cancer therapies. Dr. Javidi’s experience also includes project management and leading research teams, further honing his ability to translate complex genetic data into actionable clinical insights.

Research Interest

Dr. Javidi’s primary research interests lie in understanding the molecular mechanisms that drive cancer progression and exploring therapeutic interventions. His studies have delved into the role of microRNAs in cancer, stem cell therapies, and the cytotoxic effects of natural compounds on cancer cells. The intersection of cancer treatment with viral infections, particularly the implications of COVID-19 on cancer patients, has been a significant focus of his recent work. This integrative approach not only addresses the biological aspects of cancer but also considers the broader clinical implications, aiming to improve outcomes for patients facing dual health challenges.

Awards

Throughout his career, Dr. Javidi has received several accolades in recognition of his academic and research achievements. He was awarded the first rank upon graduating from his Ph.D. program and earned the third rank in the National Ph.D. entrance exam. His innovative research has led to a national patent on producing differentiated cells using nanocarrier-loaded curcumin. He was also recognized as an elected researcher at an international symposium on imaging applications in preclinical experiments, underscoring his standing as a promising scientist in oncology.

Publications

Javidi MA, et al. Hypericin Induces Apoptosis in MDA-MB-175-VII Cells, Archives of Iranian Medicine, 2018 (Cited by 23).

Javidi MA, et al. Verapamil Inhibits Mitochondria-Induced Reactive Oxygen Species, Oxidative Medicine and Cellular Longevity, 2020 (Cited by 45).

Javidi MA, et al. Investigating Curcumin Potential for Diabetes Cell Therapy, Life Sciences, 2019 (Cited by 38).

Javidi MA, et al. Cytotoxic and Apoptogenic Effects of Hypericin on MCF-7 Human Breast Cancer Cell Line, Cancer Cell International, 2016 (Cited by 56).

Javidi MA, et al. MicroRNA-Mediated Regulation of Epithelial to Mesenchymal Transition in Cancer, Pathology and Oncology Research, 2016 (Cited by 29).

Javidi MA, et al. Dendrosomal Nanocurcumin as a Compound for In Vitro Elimination of Undifferentiated Stem Cells, Experimental and Clinical Endocrinology & Diabetes, 2015 (Cited by 47).

Conclusion

Dr. Mohammad Amin Javidi is an accomplished young scientist whose research on molecular genetics and cancer treatment places him in an excellent position for the Young Scientist Award. His commitment to advancing cancer research is evident in his academic achievements, innovative studies, and numerous publications. While his research has already made significant contributions to the field, his potential for future advancements, particularly in the context of integrative oncology and the implications of COVID-19, marks him as a valuable candidate for recognition in the scientific community.